EFFICACY AND SAFETY OF ROFLUMILAST CREAM 0.15% IN ADULTS AND CHILDREN AGED 6 AND OLDER WITH MILD TO MODERATE ATOPIC DERMATITIS IN TWO PHASE 3 INTEGUMENT TRIALS

被引：0
|
作者：
Simpson, E. [1 ]
Eichenfield, L. F. [2 ,3 ]
Gooderham, M. [4 ,5 ]
Gonzalez, M. [6 ]
Hebert, A. A. [7 ]
Papp, K. A. [8 ]
Prajapati, V [9 ,10 ]
Krupa, D. [11 ]
Burnett, P. [11 ]
Berk, D. R. [11 ]
Higham, R. [11 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Rady Childrens Hosp, San Diego, CA 92103 USA
[4] Prob Med Res, SKiN Ctr Dermatol, Peterborough, ON, Canada
[5] Queens Univ, Peterborough, ON, Canada
[6] Pediat Skin Res LLC, Miami, FL USA
[7] UT Hlth McGovern Med Sch, Houston, TX USA
[8] Prob Med Res & Alliance Clin Res, Waterloo, ON, Canada
[9] Univ Calgary, Dermatol Res Inst, Skin Hlth & Wellness Ctr, Calgary, AB, Canada
[10] Prob Med Res, Calgary, AB, Canada
[11] Arcutis Biotherapeut Inc, Westlake Village, CA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO136
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [31] Safety, efficacy, and pharmacokinetics of crisaborole ointment, 2%, in infants aged 3 to < 24 months with mild to moderate atopic dermatitis
    Schlessinger, Joel
    Shepard, Julie S.
    Gower, Richard G.
    Su, John C.
    Lynde, Charles
    Purohit, Vivek S.
    Takiya, Liza
    Werth, John L.
    Zang, Chuanbo
    Vlahos, Bonnie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB168 - AB168
  • [32] Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials
    Silverberg, Jonathan I.
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Simpson, Eric L.
    Gold, Linda Stein
    Bissonnette, Robert
    Papp, Kim A.
    Browning, John
    Kwong, Pearl
    Korman, Neil J.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Somerville, Matthew C.
    Tallman, Anna M.
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (03) : 457 - 465
  • [33] Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis
    Ma, Lin
    Tao, Xiaohua
    Liu, Sujun
    Cheng, Hao
    Fang, Ruihua
    Zhao, Yan
    Cha, Amy
    Encinas, Gerardo A.
    Zhou, Yangmei
    Deng, Yujie
    Zhang, Jianzhong
    DERMATOLOGY AND THERAPY, 2024, 14 (05) : 1229 - 1243
  • [34] Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis
    Eichenfield, Lawrence F.
    Call, Robert S.
    Forsha, Douglass W.
    Fowler, Joseph, Jr.
    Hebert, Adelaide A.
    Spellman, Mary
    Gold, Linda F. Stein
    Van Syoc, Merrie
    Zane, Lee T.
    Tschen, Eduardo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (04) : 641 - +
  • [35] Safety Of Crisaborole In Patients Aged 3 To <24 Months With Mild-To-Moderate Atopic Dermatitis
    Shepard, Julie S.
    Schlessinger, Joel
    Gower, Richard G.
    Su, John C.
    Lynde, Charles
    Cha, Amy
    Graham, Daniela
    Takiya, Liza
    Werth, John L.
    Zang, Chuanbo
    Vlahos, Bonnie
    PEDIATRICS, 2021, 147 (03)
  • [36] Efficacy and safety of ruxolitinib cream among adolescents with atopic dermatitis: Pooled Results from two phase 3 studies
    Eichenfield, Lawrence F.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Paller, Amy S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB158 - AB158
  • [37] Efficacy and safety of pimecrolimus cream 1% in infants with mild-to-moderate atopic dermatitis: a randomised 5-year study
    Nieto, A.
    For, P.
    ALLERGY, 2012, 67 : 16 - 17
  • [38] Efficacy and safety of crisaborole ointment in Chinese and Japanese patients aged=2 years with mild-to-moderate atopic dermatitis
    Ma, Lin
    Zhang, Litao
    Kobayashi, Michiko
    Tao, Xiaohua
    Qian, Qiufang
    Cheng, Hao
    Liu, Sujun
    Zhou, Yangmei
    Chen, Yayuan
    Zhang, Jianzhong
    JOURNAL OF DERMATOLOGY, 2023, 50 (07): : 847 - 855
  • [39] CRISABOROLE OINTMENT PROVIDES EARLY RELIEF OF PRURITUS IN TWO PHASE 3 CLINICAL TRIALS IN PATIENTS WITH MILD OR MODERATE ATOPIC DERMATITIS
    Guttman-Yasky, Emma
    Yosipovitch, Gil
    Murrell, Dedee
    Ha-Nifin, Jon
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) : 1015 - 1016
  • [40] Crisaborole ointment provides early relief of pruritus in two phase 3 clinical trials in patients with mild or moderate atopic dermatitis
    Guttman-Yassky, E.
    Yosipovitch, G.
    Murrell, D.
    Hanifin, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S194 - S194
12345